Sanofi
France Stops Development of Sanofi mRNA Vaccine against Covid
Sanofi is dropping plans to develop its mRNA Covid-19 vaccine despite positive results in phases 1 and 2 because of Pfizer/BioNTech and Moderna's dominance in the market, the French pharma corporation announced on Tuesday.
Europe is dancing on the brink of disaster
According to previous data, the EU managed to administer about 8.9 million doses, or two doses per 100 inhabitants. The United States and Great Britain have so far vaccinated seven, that is to say, 10.5 inhabitants per 100, respectively, and Israel is currently at 43.
- Read more about Europe is dancing on the brink of disaster
- Log in to post comments
Sanofi to help produce 100 mln Pfizer/BioNTech vaccine doses
Sanofi will fill and pack millions of doses of Pfizer's Covid-19 vaccine from July in an effort to help meet the huge demand for the US drugmaker's shots.
The French company will aim to help supply more than 100 million doses of the vaccine this year from its German plant in Frankfurt, CEO Paul Hudson told Le Figaro newspaper on Tuesday.
UK to Spend 3.7 Billion Pounds on Vaccines and Will Take Liability for Claims
Britain has agreed to spend 3.7 billion pounds on Covid-19 vaccines and in most cases will bear the liability if claims are made against the pharmaceutical companies involved.
European Commission: First Agreement on a Potential Vaccine Against COVID-19
Today, the European Commission has reached a first agreement with the pharmaceutical company AstraZeneca to purchase a potential vaccine against COVID-19 as well as to donate to lower and middle income countries or re-direct to other European countries.
EU to Buy 200 Million Doses of the Potential COVID-19 Vaccine From Johnson & Johnson
The European Commission has concluded exploratory talks with Johnson & Johnson to buy 200 million doses of a potential COVID-19 vaccine, the EU executive and the U.S. pharmaceutical company said on Thursday.
Pharma giant Sanofi charged in misuse of epilepsy drug
Sanofi, one of France's largest pharmaceutical companies, is being charged by French prosecutors for its failure to fully inform the public and causing harm with its epilepsy drug Depakine.
Sanofi buys US company in $11.6 bln agreement
French pharmaceutical firm Sanofi said yesterday it had reached an agreement to purchase U.S. biotech company Bioverativ, which specializes in treatments for hemophilia and rare blood disorders, for $11.6 billion (9.5 billion euros).
- Read more about Sanofi buys US company in $11.6 bln agreement
- Log in to post comments
Drug makers warn Greek medicine supply 'may be in jeopardy'
Drug makers said on Monday they would continue to ship medicines to Greece in coming weeks, despite mounting unpaid bills, but warned supplies could be in jeopardy if Europe did not take emergency action.
Iraqi man who lost five sons to AIDS in weary fight for justice
First one of his sons died, then another and another. By 1996, Khalid al-Jabor had lost five children to AIDS, all victims of contaminated blood allegedly exported to Iraq by a French firm now owned by drug giant Sanofi.